Blog Category:

The Role of Targeted Therapy in Health-related Quality of Life in Generalized Myasthenia Gravis

Generalized Myasthenia Gravis (gMG) is a chronic neuromuscular disorder that significantly impacts patients’ health-related quality of life (HRQoL). Despite advancements in disease management, many individuals with gMG continue to experience debilitating symptoms, persistent physical and mental fatigue, and challenges in …

Essential Insights That Every OB/GYN Should Know About HIV

There is great importance to discussing HIV with patients of child-bearing age, and discussing HIV treatment and potential perinatal transmission with patients living with HIV who are considering or have become pregnant, given that perinatal transmission may be vastly minimized. …

HIV and HEDIS: What Do Clinicians Need to Know

One of the most essential duties of individuals who care for people living with HIV (PLWH) is to ensure that their health care is of the highest quality. The National Committee for Quality Assurance (NCQA) has developed the Healthcare Effectiveness …

Psoriasis Progress: Bridging Knowledge Gaps in Emerging Therapies for Clearer Futures

The treatment of psoriasis (PsO), a chronic, autoimmune disorder causing skin cells to build up and become inflamed, is continually evolving especially with the use of IL-23 targeting therapy. Health care practitioners (HCPs), including dermatologists and other members of the …

Diagnosis of AD and Treatment with SDM

It is critically important to diagnosis Alzheimer’s disease (AD) early in the disease course. Health care professionals (HCPs) are positioned to attain this by implementing a multidisciplinary team (MDT) approach to serve the diverse population of patients living with AD …

Precision Rules in Medicine: The Evidence Propelling IBD Treatments to Hit the Target

Precision medicine calls for the delivery of treatment that is informed by important disease features. In the treatment of patients with inflammatory bowel disease (IBD), precision medicine refers to biomarkers capable of informing diagnosis, predicting disease severity and activity, and …

Closing Gaps in Care: Re-framing Treatment Approaches from Reactive to Proactive in IBD

Inflammatory bowel disease (IBD) refers a group of chronic inflammatory disease affecting the intestines; namely, ulcerative colitis (UC) and Crohn’s disease (CD). IBD affects between 2.4 and 3.1 million adults in the United States, conferring substantial disease burden. Despite therapeutic …

Casting the Net: Precision Medicine for Greater Outreach and Better Outcomes in IBD

The role of precision medicine in the treatment of IBD has been increasingly recognized as essential for improving patient outcomes. Precision medicine aims to tailor therapeutic approaches based on individual patient characteristics, including genetic, molecular, and environmental factors. This personalized …